These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 5705749)

  • 21. [Changes in imipramine levels in various organs after intravenous injection].
    Evreux JC; Magnien JM; Demiaux JP; Faucon G; Badinand A
    C R Seances Soc Biol Fil; 1968; 162(8):1529-33. PubMed ID: 4238175
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma imipramine levels and demethylase activity in the liver of stressed animals.
    Krulík R; Farská I; Jindrová O
    Neuropsychobiology; 1981; 7(1):12-6. PubMed ID: 7465017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imipramine metabolites in blood of patients during therapy and after overdose.
    Gram LF; Bjerre M; Kragh-Sørensen P; Kvinesdal B; Molin J; Pedersen OL; Reisby N
    Clin Pharmacol Ther; 1983 Mar; 33(3):335-42. PubMed ID: 6825388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species differences in pulmonary N-oxidation of chlorpromazine and imipramine.
    Ohmiya Y; Mehendale HM
    Pharmacology; 1984; 28(5):289-95. PubMed ID: 6728903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro biotransformation of amitriptyline and imipramine with rat hepatic S9 fraction: evaluation of the toxicity with Spirotox and Thamnotoxkit F Tests.
    Nałecz-Jawecki G
    Arch Environ Contam Toxicol; 2008 Feb; 54(2):266-73. PubMed ID: 17926082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imipramine level in experimental animals after repeated application.
    Fliegerová O; Krulík R
    Act Nerv Super (Praha); 1978 Dec; 20(4):248-9. PubMed ID: 735717
    [No Abstract]   [Full Text] [Related]  

  • 27. First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotype.
    Brøsen K; Gram LF
    Clin Pharmacol Ther; 1988 Apr; 43(4):400-6. PubMed ID: 3356084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolism and excretion of [14C]imipramine in an experimental hepatitis.
    Hackett AM; Shaw IC; Griffiths LA
    Xenobiotica; 1984 Jun; 14(6):491-9. PubMed ID: 6475108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of lofepramine and imipramine in liver microsomes from rat and man.
    Strandgården K; Gunnarsson PO
    Xenobiotica; 1994 Aug; 24(8):703-11. PubMed ID: 7839694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of genetic or chemically induced diabetes on imipramine metabolism. Respective involvement of flavin monooxygenase and cytochrome P-450-dependent monooxygenases.
    Rouer E; Lemoine A; Cresteil T; Rouet P; Leroux JP
    Drug Metab Dispos; 1987; 15(4):524-8. PubMed ID: 2888626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of extrahepatic cholestasis on metabolism and biliary excretion of imipramine.
    Gigon PL
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):211-21. PubMed ID: 1147718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of dose on first-pass kinetics of 14C-imipramine in the isolated perfused rat liver.
    Beaubien AR; Pakuts AP
    Drug Metab Dispos; 1979; 7(1):34-9. PubMed ID: 35324
    [No Abstract]   [Full Text] [Related]  

  • 33. N-oxide formation and related reactions in drug metabolism.
    Bickel MH
    Xenobiotica; 1971; 1(4):313-9. PubMed ID: 4368948
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduction of tertiary amine N-oxides by rat liver mitochondria.
    Sugiura M; Kato R
    J Pharmacol Exp Ther; 1977 Jan; 200(1):25-32. PubMed ID: 13201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species and substrate differences of liver microsomal N-dealkylation and N-oxidation of tertiary amines and N-dealkylation of N-oxides.
    Bickel MH; Willi P; Gigon PL
    Xenobiotica; 1971; 1(4):533-4. PubMed ID: 4277658
    [No Abstract]   [Full Text] [Related]  

  • 36. Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization.
    Bhamre S; Bhagwat SV; Shankar SK; Williams DE; Ravindranath V
    J Pharmacol Exp Ther; 1993 Oct; 267(1):555-9. PubMed ID: 8229786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of an experimental liver cirrhosis upon the metabolism of diazepam and imipramine hydrochloride in the rat.
    Trennery PN; Waring RH
    Xenobiotica; 1985 Oct; 15(10):813-23. PubMed ID: 4072248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demethylation of imipramine and antitetrabenazine effect in the catalepsy and ptosis test.
    Michaelis W; Stille G
    Life Sci; 1968 Jan; 7(1):99-106. PubMed ID: 5636631
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of imipramine metabolism following barbiturate administration [proceedings].
    Hewick DS; Sparks RG; Stevenson IH; Watson ID
    Br J Clin Pharmacol; 1977 Jun; 4(3):399P. PubMed ID: 901725
    [No Abstract]   [Full Text] [Related]  

  • 40. Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs.
    Ishizaki J; Yokogawa K; Ichimura F; Ohkuma S
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1088-98. PubMed ID: 10945864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.